Hims stock launched by double digits Tuesday after the company inked a deal to sell Novo Nordisk's (NVO) weight-loss drug, Wegovy, on its telehealth platform.
Hims & Hers' stock surged over 20% on Tuesday after Novo Nordisk announced a partnership with telehealth platforms to provide patients with the weight loss drug Wegovy.
Patients will be able to access the popular GLP-1 through Novo Nordisk's online pharmacy, NovoCare, directly from Hims & Hers and telehealth providers Ro and LifeMD.
Powered By: Pharmacy HQ.